Critical Analysis of the Ability of the Endorectal Coil Magnetic Resonance Imaging Scan to Predict Pathologic Stage, Margin Status, and Postoperative Prostate-Specific Antigen Failure in Patients with Clinically Organ-Confined Prostate Cancer

Journal of Clinical Oncology

Volumn 14, Issue 6, 1996, Pages 1770-1777

  D'Amico, Anthony V ^a   Whittington, Richard ^b   Malkowicz, S Bruce ^b   Schultz, Delray ^b   Schnall, Mitch ^b   Tomaszewski, John E ^b   Wein, Alan ^b  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER CLASSIFICATION; DIAGNOSTIC ACCURACY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; SCORING SYSTEM; TREATMENT FAILURE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY; COMBINED MODALITY THERAPY; HUMANS; LEUPROLIDE; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0029993112     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.6.1770     Document Type: Article

References (14)

1. Rifkin MD, Zerhouni A, Gatsonis CA, et al: Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med 323:621-629, 1990
2. Platt JF, Bree RL, Schwab RE: The accuracy of CT in the staging of prostatic carcinoma. Am J Radiol 149:315-321, 1987
3. Chelsky MJ, Schnall MD, Seidmon JE, et al: Use of the endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 391:150-154, 1993
4. Krebs Tl, Silverman JM: Clinical utility of endorectal surface coil imaging of the prostate gland. Radiology 275:1992 (abstr 1006)
5. D'Amico AV, Whittington R, Malkowicz SB, et al: A Multi-variable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 30:292-300, 1994
6. Beahrs OH, Henson DE, Hutter RVP, et al: American Joint Committee on Cancer, Manual for Staging Cancer (ed 4). Philadelphia, PA, Lippincott, 1992
7. Partin AW, Yoo J, Carter BH, Pearson JD, et al: The use of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150:110-115, 1993
8. Myrtle JF, Klimley PG, Ivor LP, et al: Clinical utility of prostate-specific antigen (PSA) in the management of prostate cancer, in Advances in Cancer Diagnostics. San Diego, CA, Hybritech Inc, 1986
9. Cox DR: Regression models and life tables. J R Stat Soc B 34:1-220, 1972
10. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-467, 1958
11. Schnall MD, Lenkinski RE, Pollack HM, et al: Prostate: MR imaging with an endorectal surface coil. Radiology 172:570-575, 1989
12. Schiebler ML, Schnall M, Pollack HM, et al: Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 189:339-351, 1993
13. Katz AE, Olsson CA, Raffo A, et al: Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43:765-776, 1994
14. Presti JC, Shinohara K, Hricak H, et al: Clinical parameters in the pre-operative evaluation for extracapsular extension at radical prostatectomy. J Urol 153:429A, 1995 (abstr 801)